CSF3 and lung carcinoma: For the Lewis lung cancer model, it is remarkable that even for the IL-12 pre-only treatment group, where IL-12 was administered at a dose of 50 ng, only once, at 24 hours before chemotherapy, the rise in platelet counts was statistically significant as compared to both the vehicle and G-CSF controls.